{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:40:10Z","timestamp":1789828810161,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/17\/72\/33255"],"award-info":[{"award-number":["PG\/17\/72\/33255"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000305","name":"Sight Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S001530\/1"],"award-info":[{"award-number":["MR\/S001530\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109251","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:29:55Z","timestamp":1763627395000},"page":"109251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting Tenascin-C-Toll-like Receptor 4 signalling with Adhiron-derived small molecules - a viable strategy for reducing fibrosis in systemic sclerosis"],"prefix":"10.1016","volume":"167","author":[{"given":"Thembaninkosi","family":"Gaule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie J.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Galdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Viswambharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahnavi","family":"Krishnappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Pacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"McPhillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren C.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Maqbool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109251_bb0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Sclerodema Lung Study II Investigators. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bioorg.2025.109251_bb0010","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I","article-title":"A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma","volume":"44","author":"Pope","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bioorg.2025.109251_bb0015","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"SENSCIS trial investigators. Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2025.109251_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11703","article-title":"Tenascin-C drives persistence of organ fibrosis","volume":"7","author":"Bhattacharyya","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109251_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(22)00094-7","article-title":"Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study","volume":"4","author":"Clark","year":"2022","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.bioorg.2025.109251_bb0030","first-page":"L785","article-title":"Tenascin-C deficiency attenuates TGF-\u00df-mediated fibrosis following murine lung injury","volume":"299","author":"Carey","year":"2010","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.bioorg.2025.109251_bb0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10753-021-01540-w","article-title":"Tenascin-C participates pulmonary injury induced by Paraquat through regulating TLR4 and TGF-\u03b2 signaling pathways","volume":"45","author":"Zhang","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.bioorg.2025.109251_bb0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.38901","article-title":"Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis","volume":"67","author":"Takahashi","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bioorg.2025.109251_bb0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semcdb.2022.03.019","article-title":"Tenascin-C in fibrosis in multiple organs: translational implications","volume":"128","author":"Bhattacharyya","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2025.109251_bb0050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/wound.2017.0732","article-title":"Toll-like Receptor-4 signaling drives persistent fibroblast activation and prevents fibrosis resolution in scleroderma","volume":"6","author":"Bhattacharyya","year":"2017","journal-title":"Adv Wound Care (New Rochelle)."},{"key":"10.1016\/j.bioorg.2025.109251_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/19336918.2014.987587","article-title":"Tenascin-C: form versus function","volume":"9","author":"Giblin","year":"2015","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.bioorg.2025.109251_bb0060","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm.1987","article-title":"Tenascin-C is an endogenous activator of toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease","volume":"15","author":"Midwood","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2025.109251_bb0065","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.celrep.2012.09.005","article-title":"Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155","volume":"2","author":"Piccinini","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2025.109251_bb0070","doi-asserted-by":"crossref","first-page":"ra86","DOI":"10.1126\/scisignal.aaf3596","article-title":"Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages","volume":"9","author":"Piccinini","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bioorg.2025.109251_bb0075","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"ACCESS Study Group. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.bioorg.2025.109251_bb0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/protein\/gzu007","article-title":"Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications","volume":"27","author":"Tiede","year":"2014","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bioorg.2025.109251_bb0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/bloodadvances.2024014235","article-title":"Use of Affimer technology for inhibition of \u03b12-antiplasmin and enhancement of fibrinolysis","volume":"9","author":"Pechlivani","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.bioorg.2025.109251_bb0090","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/biom14081040","article-title":"Targeting Grb2 SH3 domains with Affimer proteins provides novel insights into Ras Signalling modulation","volume":"14","author":"Tang","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2025.109251_bb0095","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/bloodadvances.2024012689","article-title":"Affimer reagents as tool molecules to modulate platelet GPVI-ligand interactions and specifically bind GPVI dimer","volume":"8","author":"Xu","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.bioorg.2025.109251_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105325","article-title":"\u201cAffimer\u201d synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1\/2 activation","volume":"299","author":"Roper","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109251_bb0105","article-title":"Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition","volume":"31","author":"Martin","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2025.109251_bb0110","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1038\/s41467-021-24316-0","article-title":"RAS-inhibiting biologics identify and probe druggable pockets including an SII-\u03b13 allosteric site","volume":"12","author":"Haza","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109251_bb0115","first-page":"1616","article-title":"Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk","volume":"10","author":"King","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.bioorg.2025.109251_bb0120","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood-2018-06-856195","article-title":"Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications","volume":"133","author":"Kearney","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2025.109251_bb0125","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1073\/pnas.1707856115","article-title":"Affimer proteins inhibit immune complex binding to Fc\u03b3RIIIa with high specificity through competitive and allosteric modes of action","volume":"115","author":"Robinson","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109251_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.molcel.2017.08.020","article-title":"Ubiquitin linkage-specific Affimers reveal insights into K6-linked ubiquitin signaling","volume":"68","author":"Michel","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2025.109251_bb0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrd3756","article-title":"Antibody-enabled small-molecule drug discovery","volume":"11","author":"Lawson","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109251_bb0140","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24903","article-title":"Affimer proteins are versatile and renewable affinity reagents","volume":"6","author":"Tiede","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.bioorg.2025.109251_bb0145","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41598-020-80354-6","article-title":"Selection and characterisation of Affimers specific for CEA recognition","volume":"11","author":"Shamsuddin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109251_bb0150","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41467-017-01718-7","article-title":"Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers","volume":"8","author":"Zuliani-Alvarez","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109251_bb0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm0603365","article-title":"Comparison of shape-matching and docking as virtual screening tools","volume":"11","author":"Hawkins","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109251_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aid. Mol. Des."},{"issue":"2013","key":"10.1016\/j.bioorg.2025.109251_bb0165","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: An ACR-EULAR Collaborative Initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioorg.2025.109251_bb0170","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F","article-title":"Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma","volume":"44","author":"Lonzetti","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bioorg.2025.109251_bb0175","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/ard.2008.106302","article-title":"The challenge of early systemic sclerosis for the EULAR scleroderma trial and research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy","volume":"68","author":"Matucci-Cerinic","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioorg.2025.109251_bb0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi consensus study from EULAR scleroderma trials and research group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioorg.2025.109251_bb0185","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bioorg.2025.109251_bb0190","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/art.40437","article-title":"Transforming growth factor \u03b2 activation primes canonical Wnt signaling through Down-regulation of Axin-2","volume":"70","author":"Gillespie","year":"2018","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bioorg.2025.109251_bb0195","article-title":"Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with very early diagnosis of systemic sclerosis (VEDOSS)","volume":"keae698","author":"Ross","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.bioorg.2025.109251_bb0200","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cellbi.2004.09.003","article-title":"Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro","volume":"28","author":"Zhang","year":"2004","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bioorg.2025.109251_bb0205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/dvdy.20109","article-title":"Expression and roles of connective tissue growth factor in Meckel\u2019s cartilage development","volume":"231","author":"Shimo","year":"2004","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bioorg.2025.109251_bb0210","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.4161\/cc.20717","article-title":"CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth","volume":"11","author":"Capparelli","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bioorg.2025.109251_bb0215","doi-asserted-by":"crossref","first-page":"28322","DOI":"10.1038\/s41598-024-79357-4","article-title":"Generating and validating renewable affimer protein binding reagents targeting SH2 domains","volume":"14","author":"Heseltine","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109251_bb0220","doi-asserted-by":"crossref","first-page":"eaan0868","DOI":"10.1126\/scisignal.aan0868","article-title":"Isolation of isoform-specific binding proteins (Affimers) by phage display using negative selection","volume":"10","author":"Tang","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bioorg.2025.109251_bb0225","doi-asserted-by":"crossref","first-page":"27260","DOI":"10.1038\/s41598-025-07918-2","article-title":"Propolis compound inhibits profibrotic TGF-\u03b21\/SMAD signalling in human fibroblasts","volume":"15","author":"Randall","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109251_bb0230","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-019-1881-3","article-title":"Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment","volume":"21","author":"Higuchi","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bioorg.2025.109251_bb0235","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1093\/rheumatology\/keae698","article-title":"Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with very early diagnosis of systemic sclerosis (VEDOSS)","volume":"64","author":"Ross","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.bioorg.2025.109251_bb0240","doi-asserted-by":"crossref","first-page":"8693","DOI":"10.3390\/ijms21228693","article-title":"Effects of tenascin C on the integrity of extracellular matrix and skin aging","volume":"21","author":"Choi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109251_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4239\/wjd.v12.i1.19","article-title":"Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC\/TLR4\/NF-\u03baB\/miR-155-5p inflammatory loop","volume":"12","author":"Zhou","year":"2021","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.bioorg.2025.109251_bb0250","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3892\/mmr.2015.3537","article-title":"Connective tissue growth factor stimulates the proliferation, migration and differentiation of lung fibroblasts during paraquat-induced pulmonary fibrosis","volume":"12","author":"Yang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2025.109251_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000318","article-title":"Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis","volume":"2","author":"Raza","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.bioorg.2025.109251_bb0260","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00262-015-1653-0","article-title":"Cutaneous keratoacanthomas\/squamous cell carcinomas associated with neutralization of transforming growth factor beta by the monoclonal antibody fresolimumab (GC1008)","volume":"64","author":"Lacouture","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bioorg.2025.109251_bb0265","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FJC.0b013e318033dfd4","article-title":"Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation","volume":"49","author":"Nishioka","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109251_bb0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2466-14-120","article-title":"Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGF\u03b21","volume":"14","author":"Estany","year":"2014","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bioorg.2025.109251_bb0275","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bph.12452","article-title":"PDGF and TGF-\u03b2 promote tenascin-C expression in subepithelial myofibroblasts and contribute to intestinal mucosal protection in mice","volume":"171","author":"Islam","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109251_bb0280","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-like receptor 4 signaling augments transforming growth factor-\u03b2 responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bioorg.2025.109251_bb0285","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160684","article-title":"Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis","volume":"7","author":"Wang","year":"2022","journal-title":"JCI Insight"}],"updated-by":[{"DOI":"10.1016\/j.bioorg.2025.109338","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000}},{"DOI":"10.1016\/j.bioorg.2025.109338","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:23:48Z","timestamp":1773033828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S0045206825011319"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109251","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Tenascin-C-Toll-like Receptor 4 signalling with Adhiron-derived small molecules - a viable strategy for reducing fibrosis in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109251"}}